An IHC stained image of tumor.
An immunohistochemically stained image showcasing tumor tissue.
The image presents tumor tissue visualized through IHC staining.
A histological section stained using IHC, highlighting tumor structures.
An IHC-stained tissue sample displaying tumor morphology.
Tumor cells are observed in this IHC-stained histopathology image.
A high-resolution IHC-stained section highlighting tumor tissue.
This image captures tumor structures stained using immunohistochemical techniques.
An IHC-prepared sample showing tumor tissue distribution.
The image provides an IHC-based visualization of tumor architecture.
A microscopic view of tumor regions stained using IHC markers.

An IHC image of Tumor stained using the D2-40 biomarker.
The image presents tumor tissue stained with the D2-40 biomarker using IHC techniques.
D2-40-stained tumor structures are visualized in this IHC micrograph.
An IHC-stained section highlights tumor tissue marked by D2-40.
D2-40-positive staining is observed in tumor tissue in this IHC-stained sample.
The immunohistochemistry image features tumor tissue with D2-40 expression.
This IHC-stained tissue section reveals tumor structures marked with D2-40.
An IHC-stained micrograph of tumor tissue exhibiting D2-40 positivity.
The presence of D2-40-expressing cells is confirmed in tumor tissue through IHC staining.
The image presents tumor structures stained with the D2-40 biomarker in an IHC tissue section.
A microscopic view of tumor tissue showing D2-40-positive staining through IHC techniques.


An image displaying tumor cells identified through D2 biomarker in immunohistochemical analysis.
The image highlights tumor cells stained for the D2-40 biomarker in an IHC analysis.
D2-40 staining in tumor cells is visible, confirming their identification through immunohistochemistry.
An IHC image displays tumor cells marked by D2-40 biomarker staining.
Tumor cells exhibiting D2-40 staining are highlighted in the immunohistochemical analysis.
A positive immunostaining reaction for D2-40 is observed in tumor cells, marking their presence.
The image presents tumor cells identified by D2-40 staining, confirming biomarker expression.
D2-40-positive staining in tumor cells is observed in the immunohistochemistry image.
Tumor structures with clear D2-40 staining are visualized in this IHC-stained section.
A distinct pattern of D2-40 staining highlights tumor cells in the immunohistochemistry analysis.
D2-40 immunostaining reveals the distribution of tumor cells in the sample.


Tumor cells with observable nuclear staining patterns, stained with D2 biomarker.
The image presents tumor cells with clear nuclear D2-40 staining patterns.
Tumor cells stained with D2-40 exhibit distinct nuclear staining, confirming biomarker expression.
An IHC image displays tumor cells with observable nuclear staining for the D2-40 biomarker.
D2-40 staining in tumor tissue highlights nuclear localization of the biomarker.
The image captures tumor cells with nuclear D2-40 staining, supporting biomarker presence.
D2-40-positive tumor cells show nuclear staining, marking potential biomarker involvement.
A strong nuclear staining pattern for D2-40 is observed in tumor cells.
D2-40 immunostaining in tumor cells reveals nuclear expression, confirming cellular localization.
The image showcases tumor cells with nuclear D2-40 staining, supporting cell cycle regulation.
A distinct nuclear staining pattern for D2-40 is highlighted in the tumor sample.


Detailed view of tumor cells with clear nuclear staining using D2 biomarker, showcasing immunohistochemical staining.
A high-magnification image presents tumor cells with clear nuclear staining for D2-40.
D2-40 staining in tumor cells appears clearly localized in the nucleus under immunohistochemical analysis.
The image provides a detailed view of nuclear D2-40 staining in tumor cells.
A close-up image highlights nuclear D2-40 staining in tumor cells, supporting biomarker expression.
Immunohistochemical staining shows clear nuclear localization of D2-40 in tumor tissue.
The presence of D2-40 nuclear staining in tumor cells is captured in this high-resolution image.
D2-40-positive tumor cells exhibit well-defined nuclear staining, confirming biomarker expression.
The image presents a detailed immunohistochemistry view of tumor cells with strong nuclear D2-40 positivity.
Tumor cell nuclei exhibit clear D2-40 staining, marking biomarker presence in immunohistochemical analysis.
A high-resolution image showcases tumor cells with precise nuclear staining using the D2-40 biomarker.

The immunohistochemistry image of the class tumor stained with the biomarker D2 shows strongly positive nuclear staining of the cells, indicating the expression of the D2 biomarker in the cells of the tumor.
The IHC image reveals strong nuclear positivity for the D2 biomarker in tumor cells, confirming its expression.
Tumor cells exhibit intense nuclear staining for the D2 biomarker, marking high expression levels.
A strong nuclear D2 staining pattern is observed in tumor tissue, highlighting biomarker presence.
D2 staining in tumor cells appears as prominent nuclear positivity, supporting its role in cellular activity.
The image presents tumor tissue with clear nuclear D2 expression, confirming biomarker localization.
A distinct nuclear staining pattern for D2 is visible in tumor cells, marking its involvement in tumor progression.
The presence of strongly stained tumor cell nuclei indicates high D2 biomarker expression.
D2-positive nuclear staining in tumor cells confirms its expression and potential regulatory role.
The tumor section shows extensive nuclear staining for D2, supporting its role in tumor biology.
Strong nuclear D2 positivity in tumor tissue suggests active biomarker involvement in cellular processes.

The immunohistochemistry image of the class tumor stained with the biomarker D2 shows a predominantly nuclear positivity, with a distinctive dot-like staining pattern.
The IHC image highlights a dot-like nuclear staining pattern for D2 in tumor cells, confirming biomarker expression.
A distinctive nuclear D2 staining pattern, characterized by dot-like positivity, is observed in tumor tissue.
D2 biomarker staining in tumor cells exhibits a unique dot-like nuclear distribution.
Tumor tissue presents a nuclear-positive D2 staining pattern, with distinct punctate localization.
A characteristic dot-like nuclear staining pattern is seen in D2-positive tumor cells.
The image reveals a predominantly nuclear staining pattern for D2, with punctate expression in tumor cells.
D2-positive staining in tumor tissue is concentrated in the nuclei, with a distinctive distribution pattern.
A well-defined dot-like nuclear staining pattern for D2 is observed in tumor cells, supporting biomarker identification.
The tumor section displays a nuclear localization of D2 with a characteristic punctate staining pattern.
D2 staining in tumor nuclei appears as discrete dot-like positivity, confirming biomarker presence.


The image shows a positive staining pattern for D2 in a tumor, indicating the presence of the biomarker.
The IHC image presents a positive D2 staining pattern in tumor cells, marking biomarker presence.
D2-positive tumor cells exhibit distinct staining, confirming biomarker expression.
A strong D2 staining pattern is visible in tumor tissue, indicating its localization.
The image highlights positive immunostaining for D2 in tumor cells, confirming its presence.
D2 biomarker expression is confirmed in tumor tissue through positive immunohistochemistry staining.
The presence of a positive D2 staining pattern in tumor cells suggests its biological significance.
D2 expression in tumor tissue is observed as a clear staining pattern, marking biomarker localization.
Tumor cells with a positive D2 staining reaction confirm the presence of the biomarker in the sample.
A distinct positive staining pattern for D2 in tumor tissue marks biomarker expression.
D2 immunostaining in tumor tissue highlights its expression, confirming biomarker presence.


The Immunohistochemistry image of the class tumor stained with the biomarker D2 shows a strong, diffuse cytoplasmic staining pattern, indicating the presence of the biomarker in the tumor cells.
The IHC image reveals strong and diffuse cytoplasmic D2 staining in tumor cells, confirming biomarker presence.
Tumor cells exhibit a widespread cytoplasmic staining pattern for D2, suggesting significant protein expression.
A diffuse cytoplasmic D2 staining pattern is observed in tumor tissue, marking biomarker localization.
D2 staining in tumor cells appears as a strong, evenly distributed cytoplasmic signal.
The image highlights tumor tissue with a strong cytoplasmic staining pattern for the D2 biomarker.
A well-defined diffuse cytoplasmic D2 staining pattern is visible in tumor cells, supporting biomarker presence.
D2-positive tumor cells exhibit uniform cytoplasmic staining, confirming its expression in the tumor.
The presence of strong, diffuse cytoplasmic D2 staining suggests extensive biomarker involvement in tumor biology.
D2 staining in tumor tissue appears predominantly cytoplasmic, indicating biomarker localization.
A strong cytoplasmic D2 staining pattern in tumor cells confirms the presence of the biomarker and its potential role in tumor progression.
